• Exchange: OTC US
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

MVRBF:US

18.3000 USD 0.00000.00%

As of 20:10:00 ET on 08/29/2014.

Snapshot for Medivir AB (MVRBF)

Open: - Day's Range: - Volume: 3,000
Previous Close: 18.3000 52wk Range: 13.2900 - 21.7500 1-Yr Rtn: -

Stock Chart for MVRBF

No chart data available.
  • MVRBF:US 18.3000
  • 1D
  • 1M
  • 1Y
18.3000
Interactive MVRBF Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for MVRBF

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) 3.2436
Relative P/E vs. SPX -
Earnings Per Share (SEK) (ttm) -
Est. EPS (SEK) (12/2014) 39.5580
Est. PEG Ratio -
Market Cap (M USD) 569.76
Shares Outstanding (M) 30.60
30 Day Average Volume 238
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 11/20/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for MVRBF

  • Revenue
  • Net Income (M/SEK)
  • Profit Margin (%)

Company Profile & Key Executives for MVRBF

Medivir AB is a medical research company. The Company develops new drugs and pharmaceutical compounds based on proteases and polymerases as target enzymes. Medivir focuses on infectious and immunological diseases including projects against HIV, jaundice, shingles, multiple sclerosis, and rheumatoid arthritis. The Company is located in Huddinge, Sweden and Cambridge, United Kingdom.

Niklas PragerPresident/CEOChristina KassbergExec VP:Finance & Administration
Paul WallaceExec VP:Business DevelopmentRein PiirExec VP:Corporate Affairs
More Company Profile & Key Executives for MVRBF

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil